A Study to Assess Pharmacokinetics and Pharmacodynamics Following Administration of BAY1093884 in Patients With Severe Hemophilia
Clinical trial NCT03481946 · COMPLETED
Trial details
- NCT number
- NCT03481946
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-10
- Primary completion
- 2018-10-17
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.